SkyWater Technology (Nasdaq: SKYT), the trusted technology realization partner, today announced that it has completed its ...

Investing.com -- Morgan Stanley (NYSE: MS) has upgraded shares of Melexis (EBR: MLXS) to Overweight, citing improving signs ...

Deriv has been awarded ‘Best Trading Experience’ at the UF Global Awards, recognizing its leadership in delivering innovative ...

WEST COVINA, CA, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- West Covina Unified School District is proud to offer ...

Investing.com -- Jefferies has downgraded Nordic Semiconductor (OL: NOD) to “underperform” from “buy,” lowering its price target to NOK102 from NOK164, citing slower expected revenue growth, rising ...

IFX Brokers is an FSCA-regulated OTC forex broker spearheaded by a team with deep experience of the forex markets. The Board of Directors has 91 years of industry experience between them, and two ...

The pivotal trial for IFx-2.0 is expected to enroll 118 across approximately 22 to 25 U.S. sites.

In the Phase 1b trial of IFx-Hu2.0, MCC among patients who progressed on pembrolizumab (anti-PD-1) or avelumab (anti-PDL-1) therapy, weekly administration of IFx-Hu2.0 for up to 3 doses followed ...

It subsequently agreed to a 3 million pound ($4 million), or 2.49 pence a share, cash takeover from IFX on April 25. Shares were down 0.06 pence, or 2.3%, at 2.50 pence in early morning European ...

Objective To investigate whether biologic-free remission can be achieved in patients with early, active axial spondyloarthritis (SpA) who were in partial remission after 28 weeks of infliximab ...

The company then agreed to a takeover from rival IFX on April 25, just hours after it was announced the firm’s chief executive would exit the company. IFX will pay 2.49p per share in the ...

The reshuffle, effective as of last Friday, comes in the wake of the recommended acquisition of Argentex by IFX Payments, disclosed on April 25, 2025. In a move to optimize board efficiency, four ...